Clinical Trials
42 trialsMK-3475-01H
Merck Sharp & Dohme LLC
MK-2400-001
Merck Sharp & Dohme LLC
A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer
Novartis
TIMELY-PLEX
Mayo Clinic
Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors
Vanderbilt-Ingram Cancer Center
Comparison of the Therapeutic Effects of Methylprednisolone and Dexamethasone on Peritumoral Edema During Radiotherapy for Brain Metastases:
The Second Affiliated Hospital of Hainan Medical University
RESPIRE-ILD
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
ADORATION
Baptist Health South Florida
BRAINS
The Netherlands Cancer Institute
CHILURSO
University Hospital, Montpellier
IMCOMG
Fondation Ophtalmologique Adolphe de Rothschild
FORUM2
Bambino Gesù Hospital and Research Institute
BRADI
Institut Cancerologie de l'Ouest
Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
National Institutes of Health Clinical Center (CC)
A Study of Durvalumab in Combination With Lenalidomide With and Without Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma
Celgene
A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma
Celgene
Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture
Regionshospitalet Silkeborg
Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Alliance for Clinical Trials in Oncology
Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.
Spanish Breast Cancer Research Group
I-HEP
Herlev Hospital
ULTRA-COVID
Fundacion GenesisCare
BMTCTN0403
National Heart, Lung, and Blood Institute (NHLBI)
CABA-V7
Erasmus Medical Center
Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
H. Lee Moffitt Cancer Center and Research Institute
Pain Outcomes Following Intralesional Corticosteroid Injections
Vanderbilt University Medical Center
Dorsal Root Ganglion Thermal Radiofrequency Versus Pulsed Radiofrequency for Metastatic Pain in Thoracic Vertebral Body
National Cancer Institute, Egypt
PRP vs Corticosteroid in Baker's Cyst
NYU Langone Health
MK-2206-003
Merck Sharp & Dohme LLC
Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer
University of Arizona
BRAIN
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
ACT-MOVE
Hoffmann-La Roche
Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)
Seattle Children's Hospital
Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome
University of California, San Diego
Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer
Dana-Farber Cancer Institute
Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,Panobinostat
H. Lee Moffitt Cancer Center and Research Institute
A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE)
Genentech, Inc.
Risk Factors Associated to Difficult-to-control Asthma
University of Sao Paulo General Hospital
Rapamycin in Relapsed Acute Lymphoblastic Leukemia
Dana-Farber Cancer Institute
A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine).
Hoffmann-La Roche
Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma
University of Sao Paulo
A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute
HD-MCL2003
Heidelberg University